Toxicological Aspects of Drug-Facilitated Crimes

Pascal Kintz

• Publisher: Academic Press
• Year: 2014
• Print ISBN: 9780124167483
• eBook ISBN: 9780124169692
• Topic: Sciences sociales
• Subtopic: Toxicologie

Toxicological Aspects of Drug-Facilitated Crimes provides readers with an overview of the field of DFC: its history, toxicological effects, analysis, interpretation of results, the roles that age, gender and race may play, and clinical presentations of these drugs. The most commonly used drugs in DFC are addressed (alcohol, cannabis, MDMA, and cocaine), as well as an emerging range of pharmaceuticals (benzodiazepines, hypnotics, sedatives, neuroleptics, histamine H1-antagonists, or anesthetics), which are becoming more widely used, but are more difficult to detect. Edited by a world-renowned expert in the field of Forensic and Analytical Toxicology, Pascal Kintz, this book investigates toxicants of emerging concern and brings together a number of experts in the field to address the most recent discoveries on DFC toxicology.- Brings together the latest research on the toxicological analysis of drug-facilitated crimes (DFC), with real-life case studies- Provides up-to-date analytical techniques for determining toxicity levels in blood, urine, and hair- Covers all types of toxicants involved in DFC, including alcohol, cannabis, MDMA, and a wide variety of pharmaceuticals

Chapter 1

The History of Drug-Facilitated Crimes in France

Gilbert Pépin

During the month of June 1982, three identical incidents were reported to the Poison Control Center of Marseille, France. They involved young girls, victims of sexual assault, who had experienced amnesia and were found by the roadside in the Aix countryside. During police questioning, they said they had been hitchhiking. One of them reported having flashbacks, describing one in which she sees a vehicle stop and the driver offer her a can of soda which she partially drinks and then throws into the street. Informed of the facts, the police find a can by the roadside. The toxicological analysis of the content revealed the presence of triazolam. The man in the vehicle is found shortly after and confessed that he would pierce a hole in the bottom of the can, then introduce a crushed triazolam tablet, seal it with a patch, and offer his victims the undamaged can. These first cases observed in France were reported in September 1983 by Poyen, Arditti and Jouglard during the 21st Annual Conference of French Poison Control Centers. The term “drug-induced submission” was proposed by the authors at that time. This term was later replaced with “chemical submission.” The crimes committed in this way were called “drug facilitated crimes” (DFCs) and included “drug facilitated sexual assaults” (DFSAs).

Keywords

chemical submission; history; DFC; DFSA

During the month of June 1982, three identical incidents were reported to the Poison Control Center of Marseille, France. They involved young girls, victims of sexual assault, who had experienced amnesia and were found by the roadside in the Aix countryside. During police questioning, they said they had been hitchhiking. One of them reported having flashbacks, describing one in which she sees a vehicle stop and the driver offer her a can of soda which she partially drinks and then throws into the street. Informed of the facts, the police find a can by the roadside. The toxicological analysis of the content revealed the presence of triazolam. The man in the vehicle is found shortly after and confessed that he would pierce a hole in the bottom of the can, then introduce a crushed triazolam tablet, seal it with a patch, and offer his victims the undamaged can. These first cases observed in France were reported in September 1983 by Poyen, Arditti and Jouglard during the 21st Annual Conference of French Poison Control Centers.¹ The term “drug-induced submission” was proposed by the authors at that time. This term was later replaced with “chemical submission.” The crimes committed in this way were called “drug facilitated crimes” (DFCs) and included “drug facilitated sexual assaults” (DFSAs). In his presentation, Poyen stated that the well-known amnesiac effects of benzodiazepine tranquilizers cause those who have ingested them unknowingly to be easily swayed, losing all capacity to judge and resist. At that time, he also spoke about children “beaten” with drugs and stated that the populations at risk were young women, the elderly and adolescents who were “robbed of their dignity as well as their money.”

A second publicized case dates from May 15, 1993, when a hostage-taker in a kindergarten in Neuilly, France, was killed by security forces. At the request of the police, a doctor prepared a cup of coffee with Gamma-OH® and Hypnovel®. The nurse who gave the coffee to the kidnapper stated that the man in question began to drink it and then spat it out, clearly suspicious of such an action. In order to prove to the public that the hostage-taker had not been killed while out of commission, toxicological tests were conducted to verify the absence of incapacitating substances in the criminal’s blood. The analyses showed a physiological concentration of gammahydroxybutyric acid (GHB) (<2 µg/mL) and the absence of midazolam (<0.1 ng/mL). In other words, there was clear evidence of an attempt at “legal” drug-induced submission by slipping midazolam into a cup of coffee. Nevertheless, given that the person ingested just one sip and then spat it out could not be considered murder. The person in question was not under the influence when he was killed by police gunfire.

In 1994, Bismuth² published clinical case studies of drug-induced submission, which at that time already demonstrated the importance of detection techniques. Indeed, the immunochemical methods used by hospital emergency services gave negative results even when prior analyses (shown by a highly indicative chart) by gas chromatography/mass-spectrometry (GC-MS) revealed the presence of triazolam. The first case was that of a 45-year-old man robbed after Halcion® was slipped into his coffee. The second was that of a man whose wife regularly administered sodium bromide to limit his sexual inclinations—it was a car accident that brought this story to light, but the husband did not wish to press charges.

In 1997, Bismuth published eight cases of what she denounced as psychological manipulation.³ The products in question were Halcion® (triazolam), Rohypnol® (flunitrazepam) and Temesta® (lorazepam).

In 1997, Pépin and coworkers also cited the case of a 50-year-old man who died of hypothermia. He was found in a doorway without a jacket on a very cold winter night. The evening before, in a nearby bar, he had consumed a beer in the company of another man. The investigation revealed that the victim’s credit card was used after his death. The toxicological analysis showed the presence in the victim’s urine of midazolam (15 ng/mL) which was administered by the SAMU (mobile emergency unit). A concentration of 13 pg/mL of 7-aminoflunitrazepam was also noted. The perpetrator, who was subsequently arrested, admitted to having added a tablet of Rohypnol® to his victim’s beer. This was his fortieth victim over the last 10 years. He said he was living off the proceeds of his crimes, but this was the first case of death among his “clients.” However, this case was not published until 2001.⁴ It was the first French case involving repeated chemical-induced submission for the purpose of stealing credit cards.

Given the increasing number of cases concerning drug-induced submission through the use of hypnotics or tranquilizers, the head of the Agence du Médicament (French health authority) decided to set up a multidisciplinary exploratory committee within the agency. It would be chaired by Professor Lagier and would meet from May to July 1997. The group published a report entitled “Thoughts on the Criminal Use of Psychoactive Substances”.⁵ Pharmacists, analysts, judicial experts (among others: Ghysel of the Police Laboratories; Kintz of the Société Française de Toxicologie Analytique, SFTA; and Pépin of the Compagnie Nationale des Biologistes et Analystes Experts, CNBAE), representatives from the three medical orders (doctors, pharmacists, dentists), representatives from the Direction Générale de la Santé (DGS), as well as clinicians (among them Mallaret, Diamant-Berger, Bismuth and Jouglard) participated in this group. Officials from the Agence du Médicament, including Alexandre, Gatignol, Guiton, Andrieu and Castot, also attended.

The group wanted to make concrete proposals, including facilitating the dissemination of information and cooperation between the different professionals involved, to ensure that cases were diagnosed under the best possible conditions and in a timely manner. Its aim was to prevent the criminal use of these products or, at the very least, to make such crimes as difficult as possible. The group also emphasized the need for medical and medico-legal care of the victims, and from the outset insisted that the toxicological analyses by immunochemistry routinely performed in hospital emergency rooms were inadequate and insufficient for the detection of the products in question, considering their short half-life and low therapeutic concentration. The report insisted that the medical profession was generally unaware of this problem, and did not take into account the medico-legal aspect of drug-induced submission, and therefore legal errors were made resulting in the release of the perpetrators.

In 1998, Ghysel, Pépin and Kintz⁶ specified the nature of the products involved, how the samples should be taken from the victims, how to preserve the samples, and which toxicology tests should be performed with the proper equipment in order to expose drug-induced submission, which they then called “chemical submission.” Dr. Samira Djezzar also set up in 1998 consultations in Paris for victims of drug-induced submission who did not wish to press charges. These victims could either go directly to his office during his shift at the Fernand Widal Hospital, or they could be sent to him by the Hôtel Dieu Hospital emergency service.

The following year, Djezzar and Dally published an article⁷ concerning the seizure of 4 kg of GHB manufactured illegally in a Paris laboratory. The press then highlighted the misuse of this synthetic molecule in the United States, where it was nicknamed the “date-rape drug,” and how it was being administered without the victims’ knowledge due to its euphoric effects. However, no cases of the possible misuse of GHB had been reported in France in the scientific journals at that time.

In 2000, Questel et al. characterized chemical-induced submission as a major public health issue.⁸ The authors reviewed a number of cases previously reported over a 4-year period in the Urgences Médico Judiciaires (UMJ) at Hôtel Dieu Hospital in Paris. Only 82 of the 128 cases of alleged chemical-induced submission were used in their study. Clinical cases showed four predominant symptoms: amnesia or partial memory loss, impaired ability to react (sedation), asthenia and anxiety proportional to amnesia. Urinary research showed 57% of the tests to be positive with 47% detecting benzodiazepines (in order of frequency: oxazepam, flunitrazepam, clobazam, lorazepam, bromazepam, chlordiazepoxide, nordazepam), and much less frequently 4.7% detected phenothiazines (levomepromazine, aceprometazine), barbiturates and tricyclic antihistamines (doxylamine). Alcohol was found in 20% of the cases. Vasseur reported a clinical case from the UMJ at Hôtel Dieu Hospital with the use of doxylamine detected by GC-MS.⁹ On June 30, 2000, the Quotidien du Médecin began to publicize the problem within the medical community in an article entitled “Tranquilizers involved in crimes.”

In 2001, Pépin and co-workers, published the case of the repeat offender mentioned above, who was the offender in 40 DFC cases.⁴ Also in 2001, Kintz presented a synthesis of his experiences as a legal expert in the domain of chemical-induced submission.¹⁰ His observations identified zolpidem as the most frequently used substance, followed by benzodiazepines (lorazepam, bromazepam, fluitrazepam), neuroleptics (haloperidol, prometazine) and narcotics (cannabis, MDMA, LSD and ketamine). He did not identify any cases of GHB.

At the 9th Annual SFTA meeting in March 2001,¹¹ nine papers addressing the clinical, toxicological and analytical aspects of benzodiazepines were presented. In addition, eight other papers were presented specifically focusing on chemical-induced submission by use of benzodiazepines, the main authors of whom were Mallaret, Kintz, Questel, Diamant-Berger, Lagier, Pépin, Gaillard, Ghysel, Goullé and Danel. A large number of cases were cited and their pharmacological, clinical and analytical aspects were discussed. At the conference, Questel and Diamond-Berger reported the cases identified in Paris following the creation of a network of clinical services including Poison Control Centers (CAP), Centre d’Evaluation et d’Informations sur la Pharmacodépendance (CEIP) and the Centre Regional de Pharmacovigilance (CRPV). One hundred and thirty-seven cases were noted between 1993 and 2001 where psychoactive products were identified. Benzodiazepines or the like were the most often found in the toxicological analysis of 102 cases (74%). All types of benzodiazepines were found, but the main ones cited were bromazepam, lorazepam, flunitrazepam and zolpidem. Using Temesta®, which had been crushed into the victims’ food, the clinical services also reported a series of 19 attacks by the same perpetrator whose motive was theft. The other products detected were: sedating antihistamines (doxylamine, hydroxyzine, buclizine) in 12 cases, neuroleptics (cyamemazine, loxapine) in seven cases, a barbiturate (phenobarbital) in five cases, trihexyphenidyl in two cases, and tramadol in one case. As Dr. Questel said:

This study clearly underlines the importance of the quality of the analytical method used for the detection of these molecules. Immunological detection must be carried out through the use of chromatographic techniques, which are the most reliable. The present results show that current analytical techniques used for detecting toxic substances, such as immunochemistry, have proven to be completely inadequate and inappropriate in detecting substances linked to chemical-induced submission. It is essential that only experienced laboratories equipped with GC-MS technology perform these analyses. These laboratories will be required to conform to the specifications established by the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS, French health agency).

Indeed, although some scientific associations such as the SFTA had already set up a quality control program for toxicology analysis laboratories, control by an official body appeared essential. As a result of the study, the expert concluded that the victims’ medico-legal care must be improved. Therefore, it appeared crucial that the appropriate information and recommendations be disseminated to both the general public and to those involved in supporting the victims, primarily the police and the medico-legal emergency hospital services.

On January 24, 2001, a meeting was held at the Inter-ministerial Mission for the Fight against Dependency and Addiction (MILDT) to determine the actions to be taken by the various structures involved. They included¹: drafting a protocol describing procedures for taking samples and analysis to be performed (AFSSAPS)²; elaborating procedures aimed at instructing and orienting the justice system (MILDT), the police and the gendarmerie; and³ writing a document to educate emergency services about the problem of chemical-induced submission (Direction Générale de la Sante/Direction des Hôpitaux et de l’Offre de Soins (DGS/DHOS)). Chemical-induced submission was then publicized in the press: “These Tranquilizers Involved in Crimes,” Le Parisien July 2, 2002, “The Date Rape Drug in Three Clicks of the Mouse,” Journal du Dimanche October 2, 2002, “The Date Rape Drug Wreaks Havoc,” Le Parisien July 1, 2002 and “Beware of the Date Rape Drug,” L’Express August 22, 2002.

On September 19, 2002, the AFSSAPS’ Narcotics and Psychotropic Drugs Unit set up a survey which would systematically collect data involving cases where psychoactive products were used. The CEIP Paris (Dr. Djezzar) was responsible for the implementation of the study and coordinating it with different CEIP, CRPV and Poison Control Centers. In late 2002, the SFTA published a special issue of the Annales de Toxicologie Analytique devoted to chemical-induced submission¹² consisting of 10 articles by 32 authors, mainly toxicological analysts. The journal stressed the absolute necessity of using a separation method coupled with a mass spectrometer if possible, in tandem with hair analysis in order to achieve conclusive results. Indeed, Pépin and Chèze¹³ showed that hair analysis was the only reliable method of detection w...

Table of contents

• Cover image
• Title page
• Table of Contents
• Copyright
• Preface
• List of Contributors
• Chapter 1. The History of Drug-Facilitated Crimes in France
• Chapter 2. Epidemiology of Drug-Facilitated Crimes and Drug-Facilitated Sexual Assaults
• Chapter 3. Drugs Involved in Drug-Facilitated Crime—Pharmacological Aspects
• Chapter 4. Ethanol- and Drug-Facilitated Crime
• Chapter 5. Memory Impairment after Drug-Facilitated Crimes
• Chapter 6. Cannabis and Drug-Facilitated Crimes
• Chapter 7. Drugs Involved in Drug-Facilitated Crimes (DFC): Analytical Aspects: 1—Blood and Urine
• Chapter 8. Drugs Involved in Drug-Facilitated Crimes (DFC): Analytical Aspects: 2—Hair
• Chapter 9. Case Reports in Drug-Facilitated Crimes: From A for Alprazolam to Z for Zopiclone
• Chapter 10. The Specific Problem of Children and Old People in Drug-Facilitated Crime Cases
• Chapter 11. Clinical Aspects of Drug-Facilitated Sexual Assault
• Index